Leads operational and governance priorities for institutional portfolios across equity and credit markets, with a track record in investment operations, compliance and portfolio oversight. Danielle N. Annechiarico brings experience working with asset managers and family offices on risk frameworks, reporting infrastructure and capital deployment strategy. Prior roles span senior operations and client-facing functions; education includes advanced business and finance credentials supporting execution of multi-asset investment programs.
Leads operational and governance priorities for institutional portfolios across equity and credit markets, with a track record in investment operations, compliance and portfolio oversight. Danielle N. Annechiarico brings experience working with asset managers and family offices on risk frameworks, reporting infrastructure and capital deployment strategy. Prior roles span senior operations and client-facing functions; education includes advanced business and finance credentials supporting execution of multi-asset investment programs.
Centers investment decision-making on governance, operational rigor and measurable risk controls, prioritizing capital preservation and scalable deployment across equity and credit sleeves. Uses robust reporting, compliance-adjacent procedures and stress testing to translate strategy into repeatable execution; favors diversified, liability-aware allocations with disciplined liquidity management and cost-conscious implementation. Seeks alignment between portfolio construction and stakeholder objectives, applying quantitative oversight and practical operational levers to optimize returns over intermediate to long-term horizons.
Centers investment decision-making on governance, operational rigor and measurable risk controls, prioritizing capital preservation and scalable deployment across equity and credit sleeves. Uses robust reporting, compliance-adjacent procedures and stress testing to translate strategy into repeatable execution; favors diversified, liability-aware allocations with disciplined liquidity management and cost-conscious implementation. Seeks alignment between portfolio construction and stakeholder objectives, applying quantitative oversight and practical operational levers to optimize returns over intermediate to long-term horizons.
| Trades 1637 | Longs Won 1190/1637 72% | Profit Factor 3.86 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $220,702.13 |
| Average Win $77,130.87 | Best Trade (Aug 13) $4.01M | Sharpe Ratio -9.84 |
| Average Loss -$53,210.6 | Worst Trade (Mar 30) -$2.36M | Z-Score 19.47 (100%) |
| Commissions $0 | Avg. Trade Length 1y 9m 3w 6d | Expectancy $41,534.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,425 | 3,982 | 3,540 | 3,097 | 2,655 | 2,212 | 1,770 | 1,327 | 885 | 442 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 32,267 | $6.64M | $9.97M | - | $3.32M | 50.04% | -7.354% |
ABBV AbbVie Inc. | 958 | $241,885 | $240,400.52 | - | -$1,484.48 | -0.61% | -2.513% |
ADBE Adobe Inc. | 20,000 | $5M | $5.01M | - | $8,528.9 | 0.17% | +1.013% |
ADI Analog Devices, Inc. | 542 | $215,564 | $199,136.22 | - | -$16,427.78 | -7.62% | +0.202% |
ALB Albemarle Corporation | 30,485 | $3.27M | $3.59M | - | $314,518.63 | 9.61% | -0.102% |
AMZN Amazon.com Inc | 30,219 | $4.52M | $8.21M | - | $3.68M | 81.45% | +15.321% |
AOR iShares Core 60/40 Balanced Allocation ETF | 4,668 | $324,519 | $319,898.04 | - | -$4,620.96 | -1.42% | +0.058% |
AVGO Broadcom Inc. | 2,513 | $598,364.68 | $978,260.64 | - | $379,895.96 | 63.49% | +0.371% |
BA Boeing Company | 37,790 | $7.33M | $8.17M | - | $838,876.14 | 11.45% | -2.155% |
BAC Bank of America Corporation | 8,487 | $257,455.84 | $525,769.65 | - | $268,313.81 | 104.22% | +0.356% |
BDX Becton, Dickinson and Company | 35,708 | $6.4M | $5.91M | - | -$481,602.77 | -7.53% | +0.103% |
BIIB Biogen Inc. | 24,720 | $4.84M | $5.02M | - | $173,953.31 | 3.59% | -2.395% |
BMY Bristol-Myers Squibb Company | 12,246 | $630,958.23 | $799,786.26 | - | $168,828.03 | 26.76% | +0.694% |
BRK-B Berkshire Hathaway Inc. | 26,186 | $9.16M | $13.4M | - | $4.23M | 46.16% | +0.365% |
BUD Anheuser-Busch InBev S.A. ADR | 6,805 | $422,062.5 | $588,496.4 | - | $166,433.9 | 39.43% | +0.395% |
BWA BorgWarner Inc. | 4,738 | $143,917.67 | $302,000.12 | - | $158,082.45 | 109.84% | -1.04% |
CGBL Capital Group Core Balanced ETF | 19,049 | $723,115 | $709,194.27 | - | -$13,920.73 | -1.93% | -0.054% |
COKE Coca-Cola Consolidated Inc. | 1,962 | $219,680.88 | $368,659.78 | - | $148,978.9 | 67.82% | -1.017% |
CRM Salesforce Inc | 4,848 | $970,512.81 | $892,128.98 | - | -$78,383.83 | -8.08% | +1.832% |
CTVA Corteva Inc. | 10,169 | $615,491.26 | $800,401.99 | - | $184,910.73 | 30.04% | -11.898% |